Gonadorelin Acetate, a peptide previously FDA approved as LutrePulse for the induction of ovulation in women with primary hypothalamic amenorrhea and sometimes used off label for conditions such as hypogonadism, has been added to the Category 1 list
As patients with BO can be entirely asymptomatic, it is difficult to screen this population group
Staying informed through authoritative sources including NICE Clinical Knowledge Summaries, NHS patient information, and guidance from the British Association of Dermatologists (BAD) and the Primary Care Dermatology Society (PCDS) and seeking professional guidance remains the safest and most effective approach to managing hair loss in the UK
Doctronic offers a revolutionary approach to healthcare with our AI Doctor, providing you with free, instant, and personalized medical advice
Peptide protocols must be evaluated and supervised by a licensed medical provider